Search Results1-20 of  40

  • 1 / 2
  • HISADA SHIGERU ID: 9000003087822

    Japan Pharmaceutical Manufacturers Association (2002 from CiNii)

    Articles in CiNii:2

    • Practical use of ICH guidelines for special toxicology studies : Questionnaire survey by JPMA.(GENERAL SESSION BY ORAL PRESENTATION)(GENOTOXICITY) (2002)
    • Practical use of ICH guidelines for carcinogenicity studies : Questionnaire survey by JPMA.(GENERAL SESSION BY POSTER PRESENTATION)(CARCINOGENICITY) (2002)
  • HISADA SHIGERU ID: 9000003122951

    Safety & Pharmacokinetics Research Department, Teikoku Hormone Mfg. Co., Ltd. (2005 from CiNii)

    Articles in CiNii:3

    • Genotoxicity screening on an early phase of drug development using Ames miniscreen assay and in vitro micronucreus test (MUTAGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting) (2003)
    • O-21 An investigation of a possible method of genotoxic screening using RT-PCR analysis of p53-regulated genes(MUTAGENICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting) (2004)
    • Relationship between the accumulation of p53 protein and the level of DNA damage induced by ENNG and mitomycin C in human hepatoma HepG2 cells(Mutagenicity, Carcinogenicity, Proceedings of the 32nd Annual Meeting) (2005)
  • HISADA Shigeru ID: 9000001955152

    Safety Research Department, Teikoku Hormone Mfg. Co., Ltd. (1995 from CiNii)

    Articles in CiNii:1

    • EFFECTS OF SUBACUTE ETHINYLESTRADIOL ADMINISTRATION ON CELL PROLIFERATION OF 5 ORGANS, INCLUDING TUMORIGENIC TARGET AND NON-TARGET ORGANS, IN MALE F344 RATS (1995)
  • HISADA Shigeru ID: 9000003108002

    Teikoku Hormone Mfg. Co., Ltd. (1999 from CiNii)

    Articles in CiNii:1

    • 21WA-03-3 In Vivo Toxicity of Aminophenylnorharman, a Product from the Reaction of Norharman and Aniline, in F344 Rats. (1999)
  • HISADA Shigeru ID: 9000003108548

    Safety & Pharmacokinetics Research Department, Teikoku Hormone Mfg. Co., Ltd. (2005 from CiNii)

    Articles in CiNii:7

    • 21D-03-1 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (1) General toxicity. (1999)
    • 22C-10-5 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (2) Immunotoxicity. (1999)
    • P-44 Some Consideration to the Significance of Serum Immunogiobulin Levels in the Immunotoxicy Testing(Proceedings of the 27th Annual Meeting) (2000)
  • HISADA Shigeru ID: 9000006791935

    Safety Research Department Developmental Research Center, ASKA Pharmaceutical Co., Ltd. (2009 from CiNii)

    Articles in CiNii:3

    • Safety assessment of biopharmaceuticals : Japanese perspective on ICH S6 guideline maintenance (2008)
    • Collaborative work on evaluation of ovarian toxicity by repeated-dose and fertility studies in female rats (2009)
    • Morphological characterization of the ovary under normal cycling in rats and its viewpoints of ovarian toxicity detection (2009)
  • HISADA Shigeru ID: 9000006924003

    Safety Research Department, Developmental Research Center, ASKA Pharmaceutical Co., Ltd. (2009 from CiNii)

    Articles in CiNii:1

    • Effects of 2- or 4-week repeated-dose administration and fertility studies with medroxyprogesterone acetate in female rats (2009)
  • HISADA Shigeru ID: 9000261035933

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2013 from CiNii)

    Articles in CiNii:1

    • Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions : correlation analysis of 142 approved drugs in Japan (2013)
  • HISADA Shigeru ID: 9000283731150

    ASKA Pharmaceutical Co., Ltd. (2012 from CiNii)

    Articles in CiNii:1

    • Collaborative work for collecting the background control data for general toxicity study in Wistar Hannover rats – comparison with SD rats (2012)
  • HISADA Shigeru ID: 9000283731228

    ASKA Pharmaceutical Co., Ltd. (2012 from CiNii)

    Articles in CiNii:1

    • Collaborative work for collecting the background control data on embryo-fetal development study in Wistar Hannover rats - comparison with SD rats (2012)
  • HISADA Shigeru ID: 9000283731425

    Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2012 from CiNii)

    Articles in CiNii:1

    • Concordance between non-clinical and clinical toxicity data II -Number of cases and prediction ability- (2012)
  • HISADA Shigeru ID: 9000283731450

    Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2012 from CiNii)

    Articles in CiNii:1

    • Concordance between non-clinical and clinical toxicity data V -Stratified analysis by the route of administration- (2012)
  • HISADA Shigeru ID: 9000283731678

    Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2012 from CiNii)

    Articles in CiNii:1

    • Data survey on predictivity for negative tumor outcomes in rat carcinogenicity studies of pharmaceuticals (2012)
  • HISADA Shigeru ID: 9000345267881

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2016 from CiNii)

    Articles in CiNii:1

    • Nonclinical safety assessment of drugs using disease model animals (2016)
  • HISADA Shigeru ID: 9000345268419

    Innovative Drug Discovery Division, ASKA Pharmaceutial Co., Ltd.|Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, The Japan Pharmaceutical Manufacturers Association (2016 from CiNii)

    Articles in CiNii:1

    • Introduction (2016)
  • HISADA Shigeru ID: 9000347140203

    Developmental Research Center, ASKA Pharmaceutical Co., Ltd. (2014 from CiNii)

    Articles in CiNii:1

    • The changes of urinary electrolyte concentration ssuggestive of influence on calcium metabolism in iodine-deficiency rats (2014)
  • HISADA Shigeru ID: 9000347140356

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association|Aska Pharmaceutical Co., Ltd. (2014 from CiNii)

    Articles in CiNii:1

    • Adverse drug reactions for 393 medicines newly approved in Japan in recent 14 years: hypertension and hypotension (2014)
  • HISADA Shigeru ID: 9000347140480

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association|ASKA Pharmaceutical Co., Ltd. (2014 from CiNii)

    Articles in CiNii:1

    • Concordance between non-clinical and clinical toxicity data -Prediction analysis of adverse reaction in the central nervous system by safety pharmacology studies- (2014)
  • HISADA Shigeru ID: 9000347140492

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers|ASKA Pharmaceutical Co., Ltd. (2014 from CiNii)

    Articles in CiNii:1

    • Correlation of clinical adverse drug reactions and toxicological findings in biopharmaceuticals in consideration of their therapeutic target (2014)
  • HISADA Shigeru ID: 9000391992609

    Non-clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association (2009 from CiNii)

    Articles in CiNii:1

    • Questionnaire Survey for Establishment of Photosafety Evaluation Procedures (2009)
  • 1 / 2
Page Top